Home/Filings/4/0001209191-23-037904
4//SEC Filing

Rowland Charles A Jr 4

Accession 0001209191-23-037904

CIK 0001748907other

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 4:30 PM ET

Size

5.6 KB

Accession

0001209191-23-037904

Insider Transaction Report

Form 4
Period: 2023-06-14
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-14+105,000105,000 total
    Exercise: $0.49Exp: 2033-06-13Ordinary Shares (105,000 underlying)
Footnotes (2)
  • [F1]All of the shares subject to this option vest upon the earlier to occur of June 14, 2024 or the date of the 2024 Annual General Meeting of the Company.
  • [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents ten Ordinary Shares.

Issuer

Orchard Therapeutics plc

CIK 0001748907

Entity typeother

Related Parties

1
  • filerCIK 0001383292

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:30 PM ET
Size
5.6 KB